The COVID-19 pandemic has been a significant concern, and vaccination has been crucial worldwide in its combat.
A research group led by Catherine Smith from St John’s Institute of Dermatology described humoral and cellular immunity.
The safety of treatment for immune-mediated diseases like psoriasis during the COVID-19 pandemic is a matter of concern. In an
Because of the growing body of evidence indicating sex differences in the clinical outcomes of coronavirus disease 2019 (COVID-19) infection,
An article recently published in the Journal of Allergy and Clinical Immunology suggests that diseases such as psoriasis and atopic
In a recent publication in Nature Communications1 a team from Friedrich-Alexander University in Germany described their findings from a cross-sectional
Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after
The SARS-CoV-2 pandemic continues to have a considerable impact on the provision of appropriate care to people with psoriasis.